2019
DOI: 10.1007/s12010-019-03163-2
|View full text |Cite
|
Sign up to set email alerts
|

Circulating miR-135 May Serve as a Novel Co-biomarker of HbA1c in Type 2 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Además, el nivel de miR-135 mostró un valor predictivo negativo significativo para los grupos con diabetes y prediabetes, lo que proporciona una gran confianza en los resultados negativos obtenidos. (13)…”
Section: Resultsunclassified
“…Además, el nivel de miR-135 mostró un valor predictivo negativo significativo para los grupos con diabetes y prediabetes, lo que proporciona una gran confianza en los resultados negativos obtenidos. (13)…”
Section: Resultsunclassified
“…Sarookhani and colleagues reported increased expression of miR-135a in the plasma of patients with T2DM and prediabetic patients compared to healthy controls [138]. Monfared et al reported similar results and also found a correlation between serum miR-135a levels and HbA1c levels in prediabetic patients [139]. In another study, Monfared and colleagues reported that miR-135a in saliva could be used as a biomarker for T2DM [140].…”
Section: Mir-135mentioning
confidence: 86%
“…Under atherosclerotic conditions, it downregulates eNOS, inhibits vascular repair mechanisms and promotes VSMC calcification [139]. Minami and colleagues reported elevated levels of miR-221 in the serum of patients with atherosclerosis [144].…”
Section: Mir-221mentioning
confidence: 99%
“…In the pathological process of diabetes, miR-135 is involved in the process of insulin resistance [30]. In a case study, miR-135a was found to be signi cantly elevated in the plasma of diabetic patients compared to healthy controls [31], not only as a marker of glycemic control, but also to target SIRT1 and affect cell proliferation and apoptosis [32]. However, only a few studies have explored why exosomal miRNAs can regulate neovascularization.…”
Section: Discussionmentioning
confidence: 99%